Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shocking: C-Section scar pain study halted early!

NCT ID NCT05696301

Symptom relief Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested if tecar therapy (a type of electrical heat treatment) could reduce pain from cesarean section scars. About 19 women with painful scars received either real tecar therapy or a fake (sham) treatment over 3 weeks, in addition to standard scar massage. The goal was to see if the therapy improved pain at 3 months after delivery. The trial was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

19 people

The number who actually took part.

Started

Jul 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult woman(≥18 years and ≤50 years), with a painful cesarean scar (VAS ≥ 4), at the 6-8 weeks postpartum visit (reimbursed by the French national health insurance fund), regardless of whether or not she is breastfeeding, * Capable of providing informed consent to participate in this study, * and affiliated with the French health insurance fund. Exclusion Criteria: * Refusal to participate, * Has a pacemaker or a neurostimulator, * Has an insulin pump, * Coagulation disorders, * Current thrombophlebitis, * Current pregnancy, * Burning sensation at the treatment area, * Current cancer, * Insensitivity to warm or to pain, * Current infection (tuberculosis, etc.), especially of the surgical site, * Current fever, * Bladder wound during cesarean, * Under guardianship or conservatorship, deprived freedom, or in the custody of correctional authorities, * Keloid scar from previous cesarean, * Previous tecar therapy, * Strong hypertension (systolic \> 150 or diastolic \> 100) or hypotension (systolic ≤90 and diastolic \< 40 mm Hg), * Dermatologic lesion in the area to be treated (eczema, psoriasis, herpes zoster, etc.), * subumbilical midline incision. * Chronic inflammatory disease. * Under a guardianship or conservatorship, deprived of freedom, or in the custody of correctional authorities.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Abdominal Pain puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal pain Cesarean section Morbidity Postpartum

Contacts and locations

Locations

  • CHU clermont-ferrand

    Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.